ADHD: Clinical Case and Viva Q&A
Clinical Case of ADHD
Clinical Case: 8-year-old boy with ADHD
Patient: Alex, an 8-year-old boy
Presenting Complaints:
- Difficulty concentrating in class
- Frequent fidgeting and inability to sit still
- Impulsive behavior, often interrupting others
- Poor academic performance despite normal intelligence
History:
Alex's parents report that he has always been an energetic child, but his behavior has become increasingly problematic since starting school. His teacher notes that he often daydreams during lessons, has trouble following instructions, and frequently disrupts the class. At home, Alex struggles to complete homework and chores, often losing or forgetting necessary items.
Clinical Observations:
- Constantly moving or fidgeting during the examination
- Difficulty maintaining eye contact
- Easily distracted by external stimuli
- Interrupts the examiner frequently
Assessment:
Based on the clinical presentation, history, and observations, Alex meets the DSM-5 criteria for Attention-Deficit/Hyperactivity Disorder, Combined Presentation. Further neuropsychological testing and a detailed evaluation of his academic performance are recommended to rule out any comorbid conditions and to develop an appropriate treatment plan.
Management Plan:
- Initiate behavioral therapy focusing on organizational skills and impulse control
- Consider pharmacological treatment with methylphenidate after discussing risks and benefits with parents
- Implement classroom accommodations (e.g., preferential seating, frequent breaks)
- Parent training in behavior management techniques
- Regular follow-up to monitor progress and adjust treatment as needed
Clinical Presentations of ADHD
Varieties of Clinical Presentations of ADHD
-
Predominantly Inattentive Presentation:
- Difficulty sustaining attention in tasks or play
- Appears not to listen when spoken to directly
- Fails to follow through on instructions and finish schoolwork
- Easily distracted by extraneous stimuli
- Forgetful in daily activities
-
Predominantly Hyperactive-Impulsive Presentation:
- Fidgets with hands or feet, squirms in seat
- Leaves seat in situations where remaining seated is expected
- Runs about or climbs excessively in inappropriate situations
- Difficulty engaging in leisure activities quietly
- Talks excessively and blurts out answers
- Difficulty waiting turn and often interrupts others
-
Combined Presentation:
- Exhibits symptoms from both inattentive and hyperactive-impulsive presentations
- Struggles with focus, organization, and impulse control
- Displays physical restlessness and verbal interruptions
-
ADHD with Emotional Dysregulation:
- Exhibits intense emotional reactions
- Struggles with mood swings and irritability
- Has difficulty regulating emotions in social situations
- May display temper outbursts or periods of sadness
-
ADHD with Executive Function Deficits:
- Significant difficulties with planning and organization
- Poor time management skills
- Struggles with prioritizing tasks
- Difficulty initiating and completing complex tasks
-
ADHD with Learning Disorders:
- Presents with comorbid specific learning disorders (e.g., dyslexia, dyscalculia)
- Academic performance significantly below expected level
- May have difficulties in reading, writing, or mathematics
-
ADHD with Anxiety:
- Displays symptoms of anxiety alongside ADHD
- May exhibit excessive worry or fear
- Physical symptoms such as restlessness or muscle tension
- Social anxiety may be prominent
-
ADHD in Adolescents:
- Symptoms may become more subtle or internalized
- Increased risk-taking behaviors
- Academic and social difficulties become more pronounced
- May struggle with time management and long-term planning
ADHD Viva Questions and Answers
30 Viva Questions and Answers Related to ADHD
-
Q: What is the full name of ADHD and how is it classified in DSM-5?
A: ADHD stands for Attention-Deficit/Hyperactivity Disorder. In the DSM-5, it is classified under Neurodevelopmental Disorders.
-
Q: What are the three main subtypes of ADHD according to DSM-5?
A: The three main subtypes are: 1. Predominantly Inattentive Presentation 2. Predominantly Hyperactive-Impulsive Presentation 3. Combined Presentation
-
Q: What is the estimated prevalence of ADHD in children worldwide?
A: The worldwide prevalence of ADHD in children is estimated to be around 5-7%, although rates can vary depending on the diagnostic criteria and methods used.
-
Q: How does the prevalence of ADHD differ between males and females?
A: ADHD is more commonly diagnosed in males than females, with a typical ratio of about 2:1 in children and 1.6:1 in adults. However, this difference may be partly due to underdiagnosis in females.
-
Q: What are the core symptoms of ADHD?
A: The core symptoms of ADHD are inattention, hyperactivity, and impulsivity. These symptoms must be persistent, present in multiple settings, and interfere with daily functioning.
-
Q: What is the minimum duration of symptoms required for an ADHD diagnosis according to DSM-5?
A: Symptoms must have been present for at least 6 months to a degree that is inconsistent with developmental level and negatively impacts social and academic/occupational activities.
-
Q: At what age should several symptoms of ADHD be present for a diagnosis in children?
A: Several inattentive or hyperactive-impulsive symptoms must be present before age 12 years for a diagnosis of ADHD in children.
-
Q: What are some common comorbidities associated with ADHD?
A: Common comorbidities include: - Oppositional Defiant Disorder (ODD) - Conduct Disorder - Anxiety Disorders - Mood Disorders (e.g., depression, bipolar disorder) - Learning Disorders - Substance Use Disorders (in adolescents and adults)
-
Q: What are the main neurotransmitters implicated in ADHD pathophysiology?
A: The main neurotransmitters implicated in ADHD are dopamine and norepinephrine. Dysfunction in these neurotransmitter systems, particularly in prefrontal cortex and striatum, is believed to contribute to ADHD symptoms.
-
Q: What is the role of genetics in ADHD?
A: ADHD has a strong genetic component, with heritability estimates ranging from 70-80%. Multiple genes are involved, each contributing a small effect. Some identified genes include those related to dopamine receptors (e.g., DRD4, DRD5) and transporters (e.g., DAT1, SLC6A3).
-
Q: What environmental factors may contribute to the development of ADHD?
A: Environmental factors that may contribute to ADHD include: - Prenatal exposure to alcohol or tobacco - Low birth weight or prematurity - Lead exposure - Nutritional deficiencies - Psychosocial adversity and stress
-
Q: What are the first-line pharmacological treatments for ADHD?
A: First-line pharmacological treatments for ADHD include: - Stimulants: methylphenidate and amphetamine derivatives - Non-stimulants: atomoxetine, guanfacine, and clonidine
-
Q: How do stimulant medications work in treating ADHD?
A: Stimulant medications increase the availability of dopamine and norepinephrine in the synaptic cleft by blocking reuptake and/or increasing release. This enhances neurotransmission in prefrontal cortex and other regions, improving attention and executive function.
-
Q: What are the potential side effects of stimulant medications used in ADHD treatment?
A: Common side effects include: - Decreased appetite and weight loss - Sleep disturbances - Headaches - Increased heart rate and blood pressure - Mood changes or irritability - Tics (in predisposed individuals)
-
Q: What is the mechanism of action of atomoxetine in ADHD treatment?
A: Atomoxetine is a selective norepinephrine reuptake inhibitor. It increases norepinephrine and dopamine levels in the prefrontal cortex, improving attention and impulse control without the stimulant effects on other brain regions.
-
Q: What non-pharmacological interventions are effective in ADHD management?
A: Effective non-pharmacological interventions include: - Behavioral therapy - Cognitive-behavioral therapy (CBT) - Parent training in behavior management - Educational interventions and accommodations - Social skills training - Mindfulness-based interventions
-
Q: What is the recommended multimodal approach to ADHD treatment?
A: The recommended multimodal approach combines: - Pharmacotherapy - Behavioral interventions - Educational support - Family education and support - Regular follow-up and monitoring
-
Q: How does ADHD presentation typically change from childhood to adulthood?
A: As individuals with ADHD age: - Hyperactivity often decreases or becomes more internalized (restlessness) - Inattention and executive function deficits may persist or become more prominent - Impulsivity may manifest as poor decision-making or risk-taking behaviors - Organizational and time management difficulties often become more apparent
-
Q: What neuroimaging findings are associated with ADHD?
A: Neuroimaging studies have shown: - Reduced total brain volume - Smaller prefrontal cortex, basal ganglia, and cerebellum volumes - Altered white matter integrity - Functional differences in fronto-striatal and fronto-parietal networks - Delayed cortical maturation
-
Q: How does ADHD impact executive functioning?
A: ADHD can affect various aspects of executive functioning, including: - Working memory - Inhibitory control - Cognitive flexibility - Planning and organization - Time management - Emotional regulation
-
Q: What are the diagnostic criteria for adult ADHD, and how do they differ from childhood criteria?
A: Adult ADHD diagnostic criteria are similar to those for children, but: - Only 5 symptoms are required (instead of 6 for children) - Symptoms must have been present before age 12 - Examples in criteria are more relevant to adult life (e.g., work-related examples) - Self-report of symptoms is given more weight
-
Q: What is the role of executive function training in ADHD management?
A: Executive function training aims to improve skills such as working memory, inhibition, and cognitive flexibility. It can involve computerized training programs, strategy instruction, and real-life practice. While promising, evidence for its effectiveness is mixed, and it's typically used as an adjunct to other treatments.
-
Q: How does ADHD affect academic performance, and what accommodations can be helpful?
A: ADHD can negatively impact academic performance through difficulties with attention, organization, and impulse control. Helpful accommodations may include: - Extended time for tests - Preferential seating - Breaking tasks into smaller steps - Use of assistive technology - Providing written instructions - Allowing movement breaks
-
Q: What is the relationship between ADHD and sleep disorders?
A: ADHD and sleep disorders often co-occur. Individuals with ADHD may experience: - Delayed sleep phase syndrome - Insomnia - Restless leg syndrome - Sleep-disordered breathing Sleep problems can exacerbate ADHD symptoms, and treating sleep issues may improve ADHD management.
-
Q: How does ADHD impact social relationships, and what interventions can help?
A: ADHD can affect social relationships through: - Difficulty reading social cues - Impulsive behavior or inappropriate comments - Trouble maintaining conversations or friendships - Poor emotional regulation Interventions that can help include: - Social skills training - Cognitive-behavioral therapy - Peer mediated interventions - Parent and teacher involvement in fostering positive social interactions
-
Q: What is the concept of executive function disorder in ADHD, and how does it relate to the core symptoms?
A: Executive function disorder in ADHD refers to difficulties in higher-order cognitive processes that enable goal-directed behavior. It's closely related to the core symptoms of ADHD: - Inattention relates to poor working memory and difficulty sustaining attention - Hyperactivity-impulsivity relates to poor inhibitory control and self-regulation Executive function deficits can explain many of the functional impairments seen in ADHD, such as difficulty with organization, time management, and emotional regulation.
-
Q: How does ADHD presentation differ in girls compared to boys?
A: ADHD presentation in girls often differs from boys in several ways: - Girls are more likely to have inattentive type ADHD - Hyperactivity may be less overt (e.g., talkative rather than physically active) - Symptoms may be more internalized (e.g., anxiety, low self-esteem) - Girls may be better at masking symptoms or compensating - Comorbid conditions like depression or anxiety may be more common These differences can lead to underdiagnosis or later diagnosis in girls.
-
Q: What are the long-term outcomes for individuals with ADHD if left untreated?
A: Untreated ADHD can lead to various negative long-term outcomes: - Lower educational achievement - Increased risk of substance abuse - Higher rates of unemployment or underemployment - More frequent job changes and lower job satisfaction - Higher rates of relationship problems and divorce - Increased risk of accidents and injuries - Higher rates of comorbid psychiatric disorders - Potential for legal problems due to impulsive behaviors
-
Q: How does ADHD affect executive functions related to motivation and reward processing?
A: ADHD impacts motivation and reward processing in several ways: - Altered dopamine signaling affects the brain's reward system - Difficulty sustaining motivation for non-preferred tasks - Tendency to seek immediate rather than delayed rewards - Reduced sensitivity to negative feedback - Difficulty in linking future goals to present actions These issues can contribute to procrastination, poor academic/work performance, and risk-taking behaviors.
